POTASSIUM CHLORIDE capsule, extended release

Maa: Yhdysvallat

Kieli: englanti

Lähde: NLM (National Library of Medicine)

Aktiivinen ainesosa:

POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152)

Saatavilla:

BluePoint Laboratories

INN (Kansainvälinen yleisnimi):

POTASSIUM CHLORIDE

Koostumus:

POTASSIUM CHLORIDE 750 mg

Antoreitti:

ORAL

Prescription tyyppi:

PRESCRIPTION DRUG

Käyttöaiheet:

BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. 1. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. 2. For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop e.g., digitalized patients or patients with significant cardiac arrhythmias, hepatic cirrhosis with ascites, states of aldosterone excess with normal renal function, potassium-losing nephropathy, and certain diarrhe

Tuoteyhteenveto:

Potassium Chloride Extended-Release Capsules USP, 10 mEq are blue opaque elongated hard gelatin capsule filled with white to off-white coated pellets and imprinting ‘amneal’ on the cap and ‘542’ on the body with white ink, each containing 750 mg microencapsulated potassium chloride (equivalent to 10 mEq K). They are available as follows: Store at 20 º to 25º C (68º to 77º F) [See USP Controlled Room Temperature]. Dispense in tight container.

Valtuutuksen tilan:

Abbreviated New Drug Application

Valmisteyhteenveto

POTASSIUM CHLORIDE- POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE
BLUEPOINT LABORATORIES
----------
POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP
(10 MEQ)
R ONLY
DESCRIPTION
Potassium Chloride Extended-Release Capsules USP, 10 mEq are oral
dosage forms of
microencapsulated potassium chloride containing 750 mg of potassium
chloride, USP equivalent to 10
mEq of potassium.
Dispersibility of potassium chloride (KCl) is accomplished by
microencapsulation and a dispersing
agent. The resultant flow characteristics of the KCl microcapsules and
the controlled-release of K
ions by the microcapsular membrane are intended to avoid the
possibility that excessive amounts of KCl
can be localized at any point on the mucosa of the gastrointestinal
tract.
Each crystal of KCl is microencapsulated by a process with an
insoluble polymeric coating which
functions as a semi-permeable membrane; it allows for the
controlled-release of potassium and chloride
ions over an eight-to-ten-hour period. Fluids pass through the
membrane and gradually dissolve the
potassium chloride within the micro-capsules. The resulting potassium
chloride solution slowly
diffuses outward through the membrane. Potassium Chloride
Extended-Release Capsules USP, 10 mEq
are electrolyte replenishers. The chemical name of the active
ingredient is potassium chloride and the
structural formula is KCl. Potassium chloride, USP occurs as a white,
granular powder or as colorless
crystals. It is odorless and has a saline taste. Its solutions are
neutral to litmus. It is freely soluble in
water and insoluble in alcohol.
The inactive ingredients are ethylcellulose, sodium lauryl sulfate and
triethyl citrate. Additionally
capsule shell contains following inactive ingredients: FD&C blue 1,
FD&C red 40, gelatin and titanium
dioxide.
CLINICAL PHARMACOLOGY
Potassium ion is the principal intracellular cation of most body
tissues. Potassium ions participate in a
number of essential physiological processes, including the maintenance
of intracellular tonicity, the
transmission of ne